Meet The Founders
Jack has a background in bringing life science and health technologies to market. His career began in the lab, however, frustrated by a lack of clinical impact he moved to commercial roles. Most recently, he helped get the first blockbuster gene therapy to market, and its start-up acquired for ~$9B.
Quin is an MD with further degrees in genetics, mathematics, computational biology, and a PhD in systems genomics from Oxford & Cambridge Universities. Quin founded his first liver genomics company 15 years ago and recently headed liver genomics for the world’s largest metabolic biopharma.